Effects of Keto5 XOGenius Beverage on Health Markers
The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health
NA · The University of Texas at Arlington · NCT06318390
This study is testing if drinking the Keto5 XOGenius beverage every day can help people at risk for heart problems and memory issues improve their health and cognitive abilities.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | The University of Texas at Arlington (other) |
| Locations | 1 site (Arlington, Texas) |
| Trial ID | NCT06318390 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of daily consumption of the Keto5 XOGenius beverage on various health outcomes related to cardiovascular diseases and neurocognitive health. It aims to assess changes in waist circumference, body weight, and body mass index (BMI) while also evaluating markers of vascular function and cognitive performance. The research focuses on individuals at risk for conditions such as hypertension and cognitive decline, exploring how a diet high in ketones may improve physiological and neurocognitive health. Participants will be monitored for changes in their health metrics over the course of the study.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy men and women aged 18-50 who are not currently taking medications for cardiovascular or metabolic conditions.
Not a fit: Patients with diabetes, significant food allergies, or those currently on medications for cardiovascular or metabolic issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to dietary recommendations that improve cardiovascular and cognitive health in at-risk populations.
How similar studies have performed: While there is emerging research on the benefits of ketone supplementation, this specific approach using the Keto5 XOGenius beverage is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women who are between the ages of 18-50 Exclusion Criteria: * Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then we may still opt to proceed with data collection. * Food allergies * Type I diabetes/Type II diabetes, and/or a history of hypoglycemia. * History of irritable bowel syndrome or inflammatory bowel disease. * Currently taking any medications that are designed to treat a cardiovascular or metabolic condition * Pregnant women * Breast feeding women * Allergy to spandex/lycra/latex * Anemia * Use of prescription stimulants
Where this trial is running
Arlington, Texas
- UT Arlington - Science and Engineering Innovation and Research Building — Arlington, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Robert M Brothers, PhD — University of Texas at Arlington
- Study coordinator: Robert M Brothers, PhD
- Email: matthew.brothers@uta.edu
- Phone: 817-272-3288
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiovascular Diseases, Hypertension, Cognitive Decline, Diet, Healthy, endothelial function, brain blood flow, cognition